Trulicity ® (dulaglutide)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Trulicity Summary of Product Characteristics (SmPC)

Trulicity® (dulaglutide): Use in Patients With Cancer

Lilly does not have information on the use of dulagutide in patients with cancer.

Detailed Information

Dulaglutide has not been studied in patients with cancer; thus, Eli Lilly and Company has no information on the use of dulaglutide in this patient population.

Date of Last Review: January 22, 2018

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Ask us a question Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question